SEARCH

SEARCH BY CITATION

References

  • 1
    Kasper D, Braunwald E, Hauser S et al. Harrison's Principles of Internal Medicine. 16th edn. New York: McGraw-Hill Professional Publishers, 2004.
  • 2
    Whiting DR, Guariguata L, Weil C et al. Diabetes Research and clinical practice IDF Diabetes Atlas: International Diabetes Federation, Brussels. Australia; Belgium: Baker IDI Heart and Diabetes Institute, 2011.
  • 3
  • 4
    American Diabetes Association. Standards of medical care in diabetes–2012. Diabetes Care 2012; 35 (Suppl. 1): S1163.
  • 5
    The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329: 97786.
  • 6
    UKPDS group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 83753.
  • 7
    Gaede P, Vedel P, Larsen N et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 38393.
  • 8
    Shichiri M, Kishikawa H, Ohkubo Y et al. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 2000; 23(Suppl. 2): B219.
  • 9
    Srinivasan BT, Jarvis J, Khunti K et al. Recent advances in the management of type 2 diabetes mellitus: a review. Postgrad Med J 2008; 84: 52431.
  • 10
    Dawson KG, Gomes D, Gerstein H et al. The economic cost of diabetes in Canada, 1998. Diabetes Care 2002; 25: 13037.
  • 11
    Simpson SH, Corabian P, Jacobs P et al. The cost of major comorbidity in people with diabetes mellitus. CMAJ 2003; 168: 16617.
  • 12
    Zimmet P. The burden of type 2 diabetes: are we doing enough? Diabetes Metab 2003; 29: 6S918.
  • 13
    National Collaborating Centre for Chronic Conditions (UK). Type 2 Diabetes: National Clinical Guideline for Management in Primary and Secondary Care. London: Royal College of Physicians, 2008.
  • 14
    Holmes J, Gear E, Bottomley J et al. Do people with type 2 diabetes and their carers lose income? (T2ARDIS-4). Health Policy 2003; 64: 2916.
  • 15
    Hex N, Bartlett C, Wright D et al. Estimating the current and future costs of type 1 and type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabet Med 2012; 29: 85562.
  • 16
    Holman RR, Paul SK, Bethel MA et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008; 359: 157789.
  • 17
    Pouwer F, Hermanns N. Insulin therapy and quality of life. A review. Diabetes Metab Res Rev 2009; 25(Suppl. 1): S410.
  • 18
    Odegard PS, Capoccia K. Medication taking and diabetes: a systematic review of the literature. Diabetes Educ 2007; 33: 101429; discussion 30-1.
  • 19
    Quilliam BJ, Simeone JC, Ozbay AB. Risk factors for hypoglycemia-related hospitalization in patients with type 2 diabetes: a nested case-control study. Clin Ther 2011; 33: 178191.
  • 20
    Supporting people and integration with long term conditions: an NHS and Social Care Model to support local innovation. Department of Health, http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4122574.pdf (accessed 20 June, 2012).
  • 21
    Moss SE, Klein R, Klein BE. Risk factors for hospitalization in people with diabetes. Arch Intern Med 1999; 159: 20537.
  • 22
    Simmons D, Wenzel H. Diabetes inpatients: a case of lose, lose, lose. Is it time to use a ‘diabetes-attributable hospitalization cost’ to assess the impact of diabetes? Diabet Med 2011; 28: 112330.
  • 23
    Williams DR, Anthony P, Young RJ et al. Interpreting hospital admissions data across the Korner divide: the example of diabetes in the north western region. Diabet Med 1994; 11: 1669.
  • 24
    Clinical Practice Research Datalink (CPRD), http://www.cprd.com/intro.asp (accessed 20 June, 2012).
  • 25
    Lawrenson R, Williams T, Farmer R. Clinical information for research; the use of general practice databases. J Public Health Med 1999; 21: 299304.
  • 26
    Hospital episode statistics, http://www.hesonline.nhs.uk (accessed 14 May, 2012).
  • 27
    Benson T. The history of the Read Codes: the inaugural James Read Memorial Lecture 2011. Inform Prim Care 2011; 19: 17382.
  • 28
    Donnan PT, Leese GP, Morris AD et al. Hospitalizations for people with type 1 and type 2 diabetes compared with the nondiabetic population of Tayside, Scotland: a retrospective cohort study of resource use. Diabetes Care 2000; 23: 17749.
  • 29
    Cleves M, Gould W, Gutierrez RG et al. An Introduction to Survival Analysis Using Stata, 3rd edn. College Station, TX: Stata Press, 2010.
  • 30
    Quality and Outcomes Framework (QOF). Department of Health, http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/Healthcare/Primarycare/Primarycarecontracting/QOF/index.htm (accessed 20 June, 2012).
  • 31
    Bo S, Ciccone G, Grassi G et al. Patients with type 2 diabetes had higher rates of hospitalization than the general population. J Clin Epidemiol 2004; 57: 1196201.
  • 32
    Aro S, Kangas T, Reunanen A et al. Hospital use among diabetic patients and the general population. Diabetes Care 1994; 17: 13209.
  • 33
    De Berardis G, D'Ettorre A, Graziano G et al. The burden of hospitalization related to diabetes mellitus: a population-based study. Nutri Metab Cardiovasc Dis 2012; 22: 60512.
  • 34
    Davis TM, Brown SG, Jacobs IG et al. Determinants of severe hypoglycemia complicating type 2 diabetes: the Fremantle diabetes study. J Clin Endocrinol Metab 2010; 95: 22407.
  • 35
    Asuncion MM, Shaheen M, Ganesan K et al. Increase in hypoglycemic admissions: California hospital discharge data. Ethn Dis 2007; 17: 53640.
  • 36
    Service FJ. Hypoglycemic disorders. N Engl J Med 1995; 332: 114452.
  • 37
    Schejter YD, Turvall E, Ackerman Z. Characteristics of patients with sulphonurea-induced hypoglycemia. J Am Med Dir Assoc 2012; 13: 2348.
  • 38
    Mäkimattila S, Korhonen P, Haukka J et al. Type of insulin and age are predictors of hospitalization due to severe hypoglycemia: the EpiHypo Study. Berlin, Germany: European Association for the Study of Diabetes (EASD), 2012.
  • 39
    van Staa T, Abenhaim L, Monette J. Rates of hypoglycemia in users of sulfonylureas. J Clin Epidemiol 1997; 50: 73541.
  • 40
    Ray NF, Thamer M, Taylor T et al. Hospitalization and expenditures for the treatment of general medical conditions among the U.S. diabetic population in 1991. J Clin Endocrinol Metab 1996; 81: 36719.
  • 41
    Aro S, Koivisto VA, Reunanen A et al. Influence of morbidity and health care structure on hospitalization among adult diabetic patients. Diabet Med 1996; 13: 37681.
  • 42
    Lee CH, Tey BH, Chew W. Epidemiology of diabetes mellitus in a regional hospital medical unit. Ann Acad Med Singapore 1993; 22: 8649.
  • 43
    Rosenthal MJ, Fajardo M, Gilmore S et al. Hospitalization and mortality of diabetes in older adults. A 3-year prospective study. Diabetes Care 1998; 21: 2315.
  • 44
    Panser LA, Naessens JM, Nobrega FT et al. Utilization trends and risk factors for hospitalization in diabetes mellitus. Mayo Clin Proc 1990; 65: 117184.
  • 45
    Goyder E, Spiers N, McNally P et al. Do diabetes clinic attendees stay out of hospital? A matched case-control study. Diabet Med 1999; 16: 68791.
  • 46
    Roesler J, Bishop D, Walseth J. Economic cost of diabetes mellitus – Minnesota, 1988. MMWR Morb Mortal Wkly Rep 1991; 40: 22931.
  • 47
    NICE. Preventing type 2 diabetes: risk identification and interventions for individuals at high risk. Issued: July 2012, NICE public health guidance 38.
  • 48
    Guo JJ, Gibson JT, Gropper DM et al. Empiric investigation on direct costs-of-illness and healthcare utilization of Medicaid patients with diabetes mellitus. Am J Manag Care 1998; 4: 143346.
  • 49
    Ashton CM, Septimus J, Petersen NJ et al. Healthcare use by veterans treated for diabetes mellitus in the Veterans Affairs medical care system. Am J Manag Care 2003; 9: 14550.
  • 50
    Gray A, Raikou M, McGuire A et al. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group. BMJ 2000; 320: 13738.
  • 51
    Khan NF, Harrison SE, Rose PW. Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br J Gen Pract 2010; 60: e12836.